The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison

Abstract Background: Care for people with amyotrophic lateral sclerosis (ALS) has altered at King’s College Hospital over the last 20 years. The clinic has been a multidisciplinary, specialist, tertiary referral centre since 1995 with a large team with integrated palliative and respiratory care since 2006. We hypothesised that these changes would improve survival. Methods: In this retrospective observational study, patients diagnosed with El Escorial definite, probable and possible ALS between 1995–1998 and 2008–2011 were followed up. The primary outcome measure was a chi-square test for the proportion of each cohort surviving. Kaplan-Meier survival analysis and Cox multivariate regression were secondary analyses. Results: There was low reporting of some interventions. Five hundred and forty-seven people were included. Survival between the cohorts was significantly different (p = 0.022) with a higher proportion surviving during 2008–2011. Survival time was 21.6 (95% CI 19.2–24.0) months in the 2008–2011 cohort compared to 19.2 years (15.6–21.6) in the 1995–1998 cohort (log rank p = 0.018). Four hundred and ninety-three cases were included in the Cox regression. Diagnostic cohort was a significant predictor variable (HR 0.79 (0.64–0.97) p = 0.023). Conclusions: These results support the hypothesis that integrated specialist clinics with multidisciplinary input improve survival in ALS.

[1]  Sarah Martin,et al.  The changing picture of amyotrophic lateral sclerosis: lessons from European registers , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  Annelot M. Dekker,et al.  Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis , 2017 .

[3]  A. Al-Chalabi,et al.  A clinical tool for predicting survival in ALS , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  R. Rojas-García,et al.  ALS: A bucket of genes, environment, metabolism and unknown ingredients , 2016, Progress in Neurobiology.

[5]  O. Hardiman,et al.  A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  P. Shaw,et al.  Gastrostomy use in motor neurone disease (MND): A review, meta-analysis and survey of current practice , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[7]  P. Shaw,et al.  The natural history of motor neuron disease: Assessing the impact of specialist care , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[8]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[9]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[10]  P. Shaw,et al.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.

[11]  G. Cumming,et al.  Inference by eye: confidence intervals and how to read pictures of data. , 2005, The American psychologist.

[12]  K. Talbot Motor neuron disease , 2004, Practical Neurology.

[13]  Afschin Gandjour,et al.  Threshold Volumes Associated With Higher Survival in Health Care: A Systematic Review , 2003, Medical care.

[14]  O. Hardiman,et al.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.

[15]  V. Meininger,et al.  A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.

[16]  H. Luft,et al.  The volume-outcome relationship: practice-makes-perfect or selective-referral patterns? , 1987, Health services research.

[17]  A. Dreher Modeling Survival Data Extending The Cox Model , 2016 .

[18]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[19]  E. Beghi,et al.  ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. , 2007, Journal of neurology.

[20]  R. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[21]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[22]  D. McFadden Conditional logit analysis of qualitative choice behavior , 1972 .